Recap: Nabriva Therapeutics Q2 Earnings

Nabriva Therapeutics NBRV reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Nabriva Therapeutics beat estimated earnings by 10.0%, reporting an EPS of $-0.18 versus an estimate of $-0.2.

Revenue was up $948 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 10.32% drop in the share price the next day.

Here's a look at Nabriva Therapeutics's past performance:

To track all earnings releases for Nabriva Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.